Page last updated: 2024-12-11

demethoxycurcumin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

demethoxycurcumin: corresponds to curcumin with one methoxy group replaced by hydrogen; isolated from rhizomes of Curcuma longa [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

demethoxycurcumin : A beta-diketone that is curcumin in which one of the methoxy groups is replaced by hydrogen. It is found in Curcuma zedoaria and Etlingera elatior. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Etlingeragenus[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Zedoariagenus[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Curcuma zedoariaspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]
Curcuma longaspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID5469424
CHEMBL ID105360
CHEBI ID65737
SCHEMBL ID431246
SCHEMBL ID13521973
SCHEMBL ID2553051
SCHEMBL ID23884878
SCHEMBL ID23884879
MeSH IDM0143551

Synonyms (71)

Synonym
LS-14764
nsc-687841
(1e,6e)-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
nsc687841
1,6-heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1e,6e)-
4-hydroxycinnamoyl(feroyl)methane
demethoxy-curcumin
curcumin ii
monodemethoxycurcumin
22608-11-3
24939-17-1
demethoxycurcumin
bhcfm
chebi:65737 ,
CHEMBL105360
bdbm50163744
(1e,6e)-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,6-diene-3,5-dione
5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one
cid_5324476
(1e,4z,6e)-5-hydroxy-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxy-phenyl)-hepta-1,4,6-trien-3-one
1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione
desmethoxycurcumin
demethoxy curcumin
(1e,6e)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
w2f8059t80 ,
1,6-heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-
feruloyl-p-hydroxycinnnamoylmethane
unii-w2f8059t80
1,6-heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)- (van)
S9280
(e,e)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione
AKOS015903509
(1e,6e)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione
(1e,6e)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-hepta-1,6-diene-3,5-dione
curcuminii
4-hydroxycinnamoyl(feruloyl)methane
33171-16-3
(1e,6e)-1-(4-hydroxy-3-methoxy-phenyl)-7-(4-hydroxyphenyl)hepta-1,6-di ene-3,5-dione
demethoxycurcumin [inci]
e-100(ii)
desmethoxycurcumin [usp-rs]
ins-100(ii)
1-(4-hydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-hepta-1,6-diene-3,5-dione
ins no.100(ii)
SCHEMBL431246
SCHEMBL13521973
p-hydroxycinnamoyl-feruloylmethane
SCHEMBL2553051
AC-34584
Q-100287
mfcd03427310
demethoxycurcumin, analytical standard
demethoxycurcumin, >=98% (hplc)
1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 9ci
p-hydroxycinnamoylferuloylmethane
feruloyl-p-coumaroylmethane
DTXSID00873751
HY-N0006A
Q5264607
(e/z)-demethoxycurcumin
6-bromo-2-pyridin-4-yl-quinoline-4-carboxylicacid
(2e)-demethoxy curcumin
A14545
CCG-267896
curcumin ii;desmethoxycurcumin;monodemethoxycurcumin
CS-0009120
A910179
BS-48948
SCHEMBL23884878
SCHEMBL23884879

Research Excerpts

Overview

Demethoxycurcumin (DMC) is a yellow pigment derived from turmeric. It is a safe and natural food-coloring additive, as well as an agent with several therapeutic properties.

ExcerptReferenceRelevance
"Demethoxycurcumin (DMC) is a yellow pigment derived from turmeric."( Demethoxycurcumin mitigates inflammatory responses in lumbar disc herniation via MAPK and NF-κB pathways in vivo and in vitro.
Chen, H; Chen, X; Jiang, R; Li, H; Li, Q; Li, Y; Lu, B; Shen, X; Xu, Y, 2022
)
2.89
"Demethoxycurcumin (DMC) is a safe and natural food-coloring additive, as well as an agent with several therapeutic properties. "( Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1.
Gonzalez, FJ; Li, S; Qin, Z; Xu, J; Yang, J; Yao, X; Yao, Z; Zhang, B; Zhang, X, 2019
)
2.23
"Demethoxycurcumin (DMC) is a key component of Chinese medicine (Turmeric) and has been proven effective in killing various cancer cells. "( Demethoxycurcumin-induced DNA Damage Decreases DNA Repair-associated Protein Expression Levels in NCI-H460 Human Lung Cancer Cells.
Chueh, FS; Chung, JG; Hsu, SC; Hsu, WH; Ji, BC; Ko, YC; Lien, JC; Lin, HY; Liu, HC; Yang, MD, 2015
)
3.3
"Demethoxycurcumin (DMC) is a major component of"( Demethoxycurcumin Preserves Renovascular Function by Downregulating COX-2 Expression in Hypertension.
Li, Y; Ren, L; Tian, D; Zhu, C, 2016
)
2.6
"The demethoxycurcumin is a nature stabilizing agent for curcumin."( [Study on stability of curcumine, demethoxycurcumin and bisdemethoxycurcumin].
Bi, R; Cui, JJ; Han, G; Zhang, WG; Zhao, LL, 2008
)
1.11
"Demethoxycurcumin (DMC) is a candidate that has been verified in several tumor types and has potential for the treatment of prostate cancer."( Demethoxycurcumin inhibits cell proliferation, migration and invasion in prostate cancer cells.
Ni, X; Shen, Y; Wang, S; Zhang, A; Zhao, Z, 2012
)
2.54

Effects

ExcerptReferenceRelevance
"Demethoxycurcumin (DMC) has been shown to exert cytotoxic effects in human cancer cells via induction of apoptosis."( Demethoxycurcumin alters gene expression associated with DNA damage, cell cycle and apoptosis in human lung cancer NCI-H460 cells in vitro.
Chung, JG; Hsia, TC; Hsiao, YT; Hsu, SC; Hsu, WH; Ko, YC; Liu, HC; Yang, ST,
)
2.3

Toxicity

ExcerptReferenceRelevance
"Mitochondrial dysfunction and oxidative stress are the main toxic events leading to dopaminergic neuronal death in Parkinson's disease (PD) and identified as vital objective for therapeutic intercession."( Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells.
Chidambaram, R; Dhanalakshmi, C; Essa, MM; Gobi, VV; Justin Thenmozhi, A; Kalandar, A; Manivasagam, T; Rajasankar, S; Ramkumar, M, 2017
)
0.76
" We claim that a compound with anti-inflammatory and antioxidant activity may ameliorate the CNT-induced toxic effect."( Multi-walled carbon nanotube-induced inhalation toxicity: Recognizing nano bis-demethoxy curcumin analog as an ameliorating candidate.
Devasena, T; Francis, AP; Ganapathy, S; Murthy, PB; Palla, VR; Ramaprabhu, S, 2018
)
0.48

Pharmacokinetics

ExcerptReferenceRelevance
" Cmax (95."( [Study on pharmacokinetics of demethoxycurcumin phospholipid complex in rats].
Hu, XY; Luo, JC; Wang, H; Zhang, JQ; Zhang, YH, 2014
)
0.69

Compound-Compound Interactions

ExcerptReferenceRelevance
" Antimalarial activity of curcuminoids-loaded liposomes alone and in combination with α/β arteether when administered intravenously, was evaluated in Plasmodium berghei infected mice."( Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice.
Aditya, NP; Banerjee, R; Chimote, G; Gunalan, K; Madhusudhan, B; Patankar, S, 2012
)
0.38
" It has been reported that the photosensitizer curcumin, in combination with ultraviolet radiation B, induces HaCaT cell apoptosis, and this effect may be due to the activation of caspase pathways."( Demethoxycurcumin in combination with ultraviolet radiation B induces apoptosis through the mitochondrial pathway and caspase activation in A431 and HaCaT cells.
Guo, WW; Huang, Q; Jiang, G; Xin, Y; Zhang, LZ; Zhang, P, 2017
)
1.9
" Curcumin reduces cell viability of renal cell carcinoma (RCC) cells when combined with TNF-related apoptosis-inducing ligand (TRAIL), a cytokine that specifically targets cancer cells, by helping overcome TRAIL resistance."( Effects of Curcumin Analogues DMC and EF24 in Combination with the Cytokine TRAIL against Kidney Cancer.
Cassidy, H; Ibáñez Gaspar, V; McCaul, J; McMorrow, T; Slattery, C, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" It appeared that co-existing curcuminoids improved the bioavailability of curcumin."( Metabolic and pharmacokinetic studies of curcumin, demethoxycurcumin and bisdemethoxycurcumin in mice tumor after intragastric administration of nanoparticle formulations by liquid chromatography coupled with tandem mass spectrometry.
Guo, D; He, R; Li, Q; Li, R; Lin, X; Qiao, X; Xiang, C; Ye, M, 2011
)
0.62
"Curcuminoid, a dietary polyphenolic compound, has poor water solubility and low bioavailability following oral administration."( Preparation and oral bioavailability study of curcuminoid-loaded microemulsion.
Chen, X; Meng, F; Ping, Q; Xiao, Y; Yang, L; Zhu, X; Zou, L, 2013
)
0.39
" Poor oral bioavailability and the low plasma concentration of curcuminoids limited their clinical use, and one of the major reasons is their rapid metabolism in vivo."( Curcuminoid metabolism and its contribution to the pharmacological effects.
Qiu, F; Wang, K, 2013
)
0.39
" However its bioavailability is low due to its limited intestinal uptake and rapid metabolism."( The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes.
Behnam, D; Frank, J; Jandasek, J; Kocher, A; Schiborr, C; Toelstede, S, 2014
)
0.4
"Both, the micronized powder and in particular the liquid micellar formulation of curcumin significantly improved its oral bioavailability without altering safety parameters and may thus be ideally suited to deliver curcumin in human intervention trials."( The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes.
Behnam, D; Frank, J; Jandasek, J; Kocher, A; Schiborr, C; Toelstede, S, 2014
)
0.4
") administration which showed enhanced bioavailability of curcuminoids in brain as compared to intravenous administration."( PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model.
Ahmad, FJ; Ahmad, I; Ahmad, N; Iqbal, Z; Samim, M; Umar, S, 2016
)
0.43
"Poor oral bioavailability of curcuminoids limited their various applications, and one of the main reasons is their rapid metabolism in vivo."( Sulfonation of curcuminoids: characterization and contribution of individual SULT enzymes.
Han, L; Jiang, K; Lu, X; Ma, Y; Meng, S; Zhang, M; Zhou, Y, 2015
)
0.42
" Conclusion:Demethoxycurcumin phospholipid complex have higher bioavailability than free demethoxycurcumin,and their preparations bioequivalence are unqualified."( [Study on pharmacokinetics of demethoxycurcumin phospholipid complex in rats].
Hu, XY; Luo, JC; Wang, H; Zhang, JQ; Zhang, YH, 2014
)
1.07
"The oral bioavailability of curcuminoids is low, but can be enhanced by incorporation into micelles."( Intratumoral Concentrations and Effects of Orally Administered Micellar Curcuminoids in Glioblastoma Patients.
Dützmann, S; Frank, J; Franz, K; Geßler, F; Hattingen, E; Kocher, A; Pilatus, U; Quick-Weller, J; Schiborr, C; Seifert, V; Senft, C; Weissenberger, J,
)
0.13
" However, little is known about variations in its pharmacokinetics and tissue bioavailability between formulations."( Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers.
Asher, GN; Dossou, KS; Hawke, RL; Kashuba, AD; Moaddel, R; Sandler, RS; Sanghvi, M; Xie, Y, 2017
)
0.46
" In this study, we investigated the bioavailability of a new γ-cyclodextrin curcumin formulation (CW8)."( Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects.
Lowery, RP; Mannan, H; Münch, G; Purpura, M; Razmovski-Naumovski, V; Wilson, JM, 2018
)
0.48
" However, low water solubility and bioavailability of DMC causes systemic elimination and prevents its clinical application."( Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.
Chen, YY; Huang, WT; Hung, CC; Lan, SJ; Lin, HY; Lin, YJ; Liu, DM; Sheu, MJ; Tu, YC, 2018
)
1.92
" However, the poor stability, solubility, in vivo bioavailability and weak activity of CU greatly limit its clinical application."( Recent advances of analogues of curcumin for treatment of cancer.
Pi, C; Wei, Y; Ye, Y; Zhao, L; Zhao, S, 2019
)
0.51
" While curcumin has been the most extensively studied of the curcuminoids, it suffers from low overall oral bioavailability due to extremely low absorption as a result of low water solubility and instability at acidic pH, as well as rapid metabolism and clearance from the body."( Demethoxycurcumin: A naturally occurring curcumin analogue for treating non-cancerous diseases.
Hatamipour, M; Johnston, TP; Ramezani, M; Sahebkar, A; Tabassi, SAS, 2019
)
1.96
" Herein, novel soluble supramolecular complexes of the two curcuminoids were firstly prepared by integrating phospholipid (PC) compound technology and a hydroxypropyl-β-cyclodextrin (HPβCD) inclusion technique to enhance the bioavailability of the curcuminoids."( Phospholipid/hydroxypropyl-β-cyclodextrin supramolecular complexes are promising candidates for efficient oral delivery of curcuminoids.
He, D; Jiang, R; Li, K; Luo, J; Wang, H; Xie, J; Xie, X; Yang, Q; Zhang, J; Zhang, Y, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" In a whole animal experiment, rats were trained in a water maze and thereafter dosed with lead and/or curcumin (CURC), demethoxycurcumin (DMC), or bisdemethoxycurcumin (BDMC) for 5 days."( Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats.
Antunes, E; Dairam, A; Daya, S; Limson, JL; Watkins, GM, 2007
)
0.84
" For curcumin-SLNs group, the dosing of 250 mg/kg of curcumin resulted in AUC((0-48 h)) of 2285 ngh/mL and C(max) of 209 ng/mL."( Metabolic and pharmacokinetic studies of curcumin, demethoxycurcumin and bisdemethoxycurcumin in mice tumor after intragastric administration of nanoparticle formulations by liquid chromatography coupled with tandem mass spectrometry.
Guo, D; He, R; Li, Q; Li, R; Lin, X; Qiao, X; Xiang, C; Ye, M, 2011
)
0.62
" Both effects were observed to increase in proportion to the cellular uptake of curcuminoids; cellular uptake increased following an increase in the dosage of curcuminoids."( The cellular uptake and cytotoxic effect of curcuminoids on breast cancer cells.
Chang, CC; Chen, TY; Fu, CF; Hsu, YC; Yang, WT, 2012
)
0.38
" It was found that the three curcumins could inhibit the proliferation of HUVEC cells induced by OX-LDL within the dosage range 4, 8, 16 mg x L(-1), with a dose-dependence."( [Study on anti-angiogenesis effect of three curcumin pigments and expression of their relevant factors].
Ding, ZS; Huang, YF; Lv, GY; Zhu, XX, 2015
)
0.42
" Finally, once-daily dosing is sufficient to maintain detectable curcuminoids at steady state in both plasma and rectal tissues."( Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers.
Asher, GN; Dossou, KS; Hawke, RL; Kashuba, AD; Moaddel, R; Sandler, RS; Sanghvi, M; Xie, Y, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (2 Product(s))

Product Categories

Product CategoryProducts
Professional Supplements1
Herbs, Botanicals & Homeopathy1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Designs for Sport Curcumin Complex - NSF Certified for Sport -- 60 SoftgelsDesigns for SportProfessional Supplements bisdemethoxycurcumin, demethoxycurcumin2024-11-29 10:47:42
Terry Naturally Curamin Headache -- 21 TabletsTerry NaturallyHerbs, Botanicals & Homeopathycitric acid, citric acid, demethoxycurcumin, Cellulose powder, maltodextrin, Vitamin B6, Vitamin B62024-11-29 10:47:42

Roles (3)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
beta-diketoneA diketone in which the two keto groups are separated by a single carbon atom.
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
diarylheptanoidA family of plant metabolites with a common 1,7-diphenylheptane structural skeleton, carrying various substituents. They are mainly distributed in the roots, rhizomes and bark of Alpinia, Zingiber, Curcuma and Alnus species.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1511035Induction of apoptosis in human SKOV3 cells at 40 umol/L after 48 hrs by annexin-V-FITC/propidium iodide staining-based flow cytometric method relative to control2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1395721Cytotoxicity against human WRL68 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
AID1511034Induction of apoptosis in human SKOV3 cells at 20 umol/L after 48 hrs by annexin-V-FITC/propidium iodide staining-based flow cytometric method relative to control2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1395720Cytotoxicity against human A431 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
AID1511036Induction of apoptosis in human SKOV3 cells at 80 umol/L after 48 hrs by annexin-V-FITC/propidium iodide staining-based flow cytometric method relative to control2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1395719Cytotoxicity against human A549 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
AID1395722Cytotoxicity against human MCF7 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
AID1395723Cytotoxicity against human DLD1 cells preincubated for 4 hrs followed by incubation in compound free media for 24 hrs by MTT assay2018European journal of medicinal chemistry, May-10, Volume: 151Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
AID1586745Drug metabolism assessed as horseradish peroxidase-mediated oxidation by measuring demethoxy-7-Norcyclopentadione formation at 50 uM after 1 hr in presence of H2O2 by LC-MS analysis2018Journal of natural products, 12-28, Volume: 81, Issue:12
A Curcumin Degradation Product, 7-Norcyclopentadione, Formed by Aryl Migration and Loss of a Carbon from the Heptadienedione Chain.
AID1511038Increase in MMP3 level in human MDA-MB-231 cells after 24 hrs by ELISA2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
AID1437812Inhibition of L-type calcium channel in Sprague-Dawley rat aortic rings assessed as reduction in phenylephrine-induced vasoconstriction at 25 uM preincubated with aortic rings followed by phenylephrine addition2017Journal of natural products, 01-27, Volume: 80, Issue:1
Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric).
AID1511039Decrease in UPA expression in human HT1080 cells2019European journal of medicinal chemistry, Oct-15, Volume: 180Recent advances of analogues of curcumin for treatment of cancer.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (177)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.56)18.7374
1990's3 (1.69)18.2507
2000's39 (22.03)29.6817
2010's112 (63.28)24.3611
2020's22 (12.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.13 (24.57)
Research Supply Index5.29 (2.92)
Research Growth Index5.72 (4.65)
Search Engine Demand Index68.12 (26.88)
Search Engine Supply Index3.54 (0.95)

This Compound (32.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (5.35%)5.53%
Reviews6 (3.21%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other171 (91.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]